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A B S T R A C T
The leaves of Chenopodium album Linn. are traditionally used for treatment of kidney dis-
eases and urinary stones. The present work investigated the effect of aqueous extract of
leaves of C. album (CAAE) on in-vitro crystallization of CaOx and brushite crystals. Crystal-
lization was studied by using nucleation and aggregation assay of calcium oxalate (CaOx)
crystals and growth assay of calcium oxalate monohydrate and brushite crystals. The effects
of CAAE and cystone on slope of nucleation and aggregation as well as growth of calcium
oxalate crystallization were evaluated spectrophotometrically. The densities of the formed
crystals were compared under microscope. The effects of CAAE and citric acid on growth
of brushite crystals were studied by using single diffusion gel growth technique, and the
parameters evaluated were length, morphology and average size of the deposited crystals.
CAAE significantly inhibited the slope of nucleation and aggregation of CaOx crystalliza-
tion, and decreased the crystal density. It also inhibited the growth and caused the dissolution
of brushite crystals. The standard drug cystone or citric acid also exhibited similar effects.
The study reveals that the leaves of C. album were found effective in the prevention of the
experimentally induced urinary stones and substantiate the traditional claim. It is con-
cluded that the leaves of C. album have beneficial inhibitory effect on in-vitro crystallization
of CaOx and CHPD (brushite) crystals.
© 2016 Mansoura University. Production and hosting by Elsevier B.V. This is an open










Urolithiasis is defined as the presence of one or more calculi
in any location within the urinary tract [1]. It is a common dis-
order estimated to occur in approximately 12% of the
population, with a recurrence rate of 70–80% in male and
47–60% in female [2]. Majority of the stones are calcium-
containing stones, especially calcium oxalate (80%) and others
are 20% [3].
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The medical management of urolithiasis involves drug treat-
ment and extracorporeal shock wave lithotripsy (ESWL). The
various therapies including thiazide as diuretic and alkali-
citrate are used to prevent the recurrence of hypercalciuria
and hyperoxaluria, which induce calculi formation, but evi-
dence for their efficacy is less [4].The surgical endoscopic stone
removal and extracorporeal shock wave lithotripsy have revo-
lutionized the treatment of urolithiasis but does not prevent
the likelihood of new stone formation [5]. Besides imposing
the high cost, shock waves in therapeutic doses may cause
acute renal injury, decrease in renal function and an increase
in stone recurrence. The recurrence of stone formation is also
very high (50–80%). In addition, persistent residual stone frag-
ments and the possibility of infection after ESWL represent a
serious problem in the treatment of stones.Thus, medical man-
agement of urolithiasis is either costly or poses serious side
effects.
The crystallization of the stone begins with increased urinary
supersaturation, with the subsequent formation of the solid
crystalline particles within the urinary tract. This is followed
by nucleation, by which stone-forming salts in supersatu-
rated urinary solution coalesce into clusters that then increase
in size by the addition of new constituents [6]. These crystals
then grow and aggregate with other crystals in solution, and
are ultimately retained and accumulated in the kidney [7].
Therefore, if this progression of crystallization can be pre-
vented, then lithiasis can also be prevented.
There is growing interest of public in herbal medicine,
particularly in the treatment of urolithiasis partly because of
limited choice in the pharmacotherapy. Data from in-vitro,
in-vivo and clinical trials reveal that phytotherapeutic agents
could be useful as either an alternative or an adjunctive
therapy in the management of urolithiasis. Many Indian plants
are useful as antilithiatic agents [5,8–13]. Hence, the Indian
medicinal plants are constantly being evaluated for possible
antilithiatic effects.
Chenopodium album L. (family: Chenopodiaceae) is a herba-
ceous vegetable plant locally known as Bathua. It is cultivated
as pot-herb and usually grown in gardens, but can be found
in the corner of early grain fields in Bombay presidency and
elsewhere in India (Kashmir and Sikkim). The medicinal prop-
erty of this plant is mainly present in leaves and seeds. The
leaves of C. album are used in ethno-medicinal practices for
treatment of kidney diseases and urinary stones. Ethnobo-
tanical studies of Aravalli region of Rajasthan (India) report the
folk medicinal uses of cooked leaves of C. album in kidney stones
and urinary tract troubles [14]. Cooked leaves of C. album are
used as traditional medicine in the Shekhavati region of Ra-
jasthan for treatment of urinary troubles and colic [15]. In
Ladakh, leaves are also used traditionally for controlling painful
urination [16]. C. album is an important medicinal weed of Mo-
radabad useful in the treatment of urinary retention and kidney
diseases [17].
In view of traditional and ethno-medicinal use of leaves of
C. album in the treatment of kidney stones, the present work
demonstrated the effect of aqueous extract of the leaves of
C. album on in-vitro crystallization of CaOx and brushite crys-
tals. As this plant is consumed as food substance by human
beings and as weed fodder by cattle, its antilithiatic property
would be good preventive option available.
2. Materials and methods
2.1. Plant material
The leaves of C. album were collected from the local market
of Gwalior in December 2012 and identified by Dr. N.K. Pandey,
Research Officer (Botany), National Research Institute for
Ayurveda-Siddha Human Resource Development, Aamkho,
Gwalior. A voucher specimen (Field Book No. 5-4/12–13/
NRIASHRD/Tech/Survey/134) of the authenticated C. album has
been deposited in the herbarium of the institute.
2.2. Drugs and chemicals
Cystone (Himalaya Drug Company) and citric acid
1-monohydrate (E. Merck (India) Ltd., Mumbai) were pur-
chased from the local market. All remaining chemicals used
in the experiment were of the highest grade commercially
available.
2.3. Preparation of aqueous extract of the leaves of
C. album (CAAE)
The leaves were separated from other extraneous matter and
subjected to shade drying. The dried leaves were subjected to
a coarse powder by using dry grinder. The powder (100g) was
soaked (maceration) in 1 L purified water and kept in dark and
dry place for 48 h at a temperature range of 20–26 °C. Chloro-
form was added in quantity of 1% total mixture to avoid
microbial growth. After 48 h, solutions were filtered by Whatman
Filter Paper No. 1. The filtered extracts were dried in a rotary
evaporator to obtain a dark brown powdery extract (13.4% w/w).
2.4. Preliminary phytochemical screening and
quantitative estimation of phytoconstituents
Preliminary phytochemical screening [18] of CAAE was carried
out to detect the presence of sterols, alkaloids, saponins, ter-
penes, tannins, phenolic substances, carbohydrates, volatile oil
and mucilage. The total phenolic content of the extracts was
determined spectrometrically [19] and expressed as milli-
gram of tannic acid equivalents (TAE) per gram of extract. Total
flavonoid content was measured by aluminum chloride colo-
rimetric assay [20] and expressed as milligram of quercetin
equivalent per gram of extract. Total saponins were deter-
mined according to the previously described methods by
Obadoni and Ochuko (2002) with little modification [21].
2.5. Effect of CAAE on in-vitro crystallization
2.5.1. In-vitro crystallization of calcium oxalate
2.5.1.1. Nucleation and aggregation assay. Nucleation and ag-
gregation assay were performed as per method previously
described by Hess et al. [2000] with minor modifications [22].
Briefly, freshly prepared solution of 10 mM calcium chloride di-
hydrate and 1.0 mM sodium oxalate, containing 200 mM NaCl
and 10 mM sodium acetate trihydrate, was adjusted to pH 5.7.
All experiments were performed at 37 °C, using a circulating
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water bath. For crystallization experiments, 25 ml of sodium
oxalate solution was transferred into a beaker and placed in
the hot plate magnetic stirrer (Model 2MLH, REMI), which was
maintained at 37 °C and constantly stirred at 800 rpm. An ad-
ditional 1 ml of distilled water/standard (cystone)/extract were
added and finally calcium chloride solution (25 ml) was added.
The optical density was measured at 620 nm in spectropho-
tometer (UV 1800, Shimadzu Corporation, Japan) after addition
of calcium containing solution, on every 15 s over 5 min and
then every 1 min over 10 min. All the experiments were per-
formed in triplicate. The final solutions were seen under a light
microscope to analyze the density of formed crystals in the
solution (Olympus, USA). Percent inhibition in the presence of
cystone or CAAE was compared with the control by the fol-
lowing formula.
The percentage inhibition was calculated as:
1 100− ( )[ ] ×Tsi Tsc
where Tsc, the turbidity slope of the control; and Tsi, the tur-
bidity slope in the presence of the inhibitor.
2.5.1.2. In vitro calcium oxalate crystal growth assay. Inhibitory
activity of CAAE against CaOx crystal growth was measured
using previously described methods [23,24]. Briefly, 20 ml each
of 4 mM calcium chloride and 4 mM sodium oxalate were added
to a 30 ml of solution, containing NaCl (90 mM) buffered with
Tris HCl (10 mM) pH 7.2.To this 600 μl of calcium oxalate mono-
hydrate (COM) crystal slurry (1.5 mg/ml acetate buffer) was
added. Consumption of oxalate begins immediately after COM
slurry addition and was monitored for 600 s by disappear-
ance of absorbance at 214 nm. One ml of CAAE (500) and CAAE
(1000 μg/ml) was added separately into this solution.The deple-
tion of free oxalate ions will decrease if CAAE inhibits calcium
oxalate crystal growth. Rate of reduction of free oxalate was
calculated using the baseline value and the value after 30 s in-
cubation with or without the extract. The relative inhibitory
activity was calculated as follows:
% Relative inhibitory activity C S C= −( )( ) × 100
where C is the rate of reduction of free oxalate without any
extract and S is the rate of reduction of free oxalate with CAAE.
2.5.2. In-vitro crystallization of brushite crystals
2.5.2.1. Growth assay. Growth assay in single diffusion gel
growth of brushite crystals was carried out according to the
methods previously described by of Joshi et al. [2005b] with little
modification [11]. Single diffusion gel growth method was fol-
lowed to grow calcium hydrogen phosphate dihydrate (CHPD).
When crystals achieved the maximum growth the inhibitive
effects of citric acid solution having different concentrations
were studied by adding them into the supernatant solution.
Glass test tubes of 2.5 cm diameter and 15 cm length were
used for growing the crystals. Five milliliters of sodium meta-
silicate solution of specific gravity 1.06 were acidified by adding
appropriate amount (2.7 ml) of orthophosphoric acid so that
5.0 pH could be obtained for the mixture, which was subse-
quently transferred into different test tubes.After gelation took
place, 10 ml of 1 M aqueous solution of calcium chloride was
carefully poured on the set gels. Crystals were found growing
very rapidly within two days from pouring the supernatant so-
lutions. Elongated platelet type and star shaped crystals were
grown in the gel. The apparent length of growing crystals was
measured under microscope at different time intervals. The
plot of apparent length of growing crystals versus time showed
that the crystals achieved maximum length on the 5th day of
pouring supernatant solution on set gel. Aqueous solution of
citric acid as a standard and CAAE was added in the same volume
as the calcium chloride solution on the 5th day after acquir-
ing the maximum length of CHPD crystals, and their effect was
studied on the growth of CHPD crystals up to the 8th day. For
pH 5.0, many crystals having star and platelet star and plate-
let type morphologies were observed. The photographs of the
test tube showing the growth of the crystals were recorded.
2.6. Statistical analysis
The data obtained were analyzed by one-way ANOVA, two-
way ANOVA and linear regression analysis wherever necessary.
A value of p < 0.05 was considered significant in all cases.
3. Results
3.1. Preliminary phytochemical screening and
quantitative estimation of phytoconstituents
CAAE showed the presence of proteins, alkaloids, saponin gly-
cosides, amino acids and flavonoids, while carbohydrates, sterols
and tannins were absent. The total phenolic and flavonoid
content of CAAE were found to be 239.8 mg TAE/g of extract
and 87.23 mg quercetin equivalents/g of extract, respectively
while the total saponins content was found to be 1.6 mg
saponins/100g of powder mass.
3.2. Effect of CAAE on in-vitro crystallization
3.2.1. In-vitro crystallization of calcium oxalate
3.2.1.1. Nucleation and aggregation assay. The changes in the
turbidity or optical density of different solutions, viz control,
cystone (1000 μg/ml), and CAAE (500 μg/ml and 1000 μg/ml), were
plotted at different time intervals. The turbidity increased lin-
early up to 5 minutes, which indicated the nucleation process
and then decreased linearly up to 15 minutes indicating the
aggregation process. CAAE (500 μg/ml and 1000 μg/ml) and
cystone (1000 μg/ml) inhibited both the rate of nucleation and
the rate of aggregation. The maximum optical density of the
solutions, viz control, cystone (1000 μg/ml) and CAAE (500 μg/
ml) and CAAE (1000 μg/ml), recorded was 0.170, 0.072, 0.122 and
0.095. The percent inhibition rates of nucleation of CaOx by
cystone (1000 μg/ml), CAAE (500 μg/ml) and CAAE (1000 μg/
ml) were found to be 58.33, 12.5 and 37.5 percent, respectively
(Fig. 1). The percent inhibition rates of aggregation of CaOx by
cystone (1000 μg/ml), CAAE (500 μg/ml) and CAAE (1000 μg/
ml) were found to be 66.66, 66.66 and 33.33 respectively (Fig. 1).
The photomicrographs of the CaOx crystals in solutions of
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control, cystone (1000 μg/ml) and CAAE (500 μg/ml and 1000 μg/
ml) showed that CaOx crystals were less denser in cystone
(1000 μg/ml), CAAE (500 μg/ml) and CAAE (1000 μg/ml) as com-
pared to control (Fig. 2).
3.2.1.2. In vitro calcium oxalate crystal growth assay. In calcium
oxalate growth assay, CAAE inhibited calcium oxalate mono-
hydrate (COM) growth. The percentage inhibition of cystone
(1000 μg/ml), CAAE (500 μg/ml) and CAAE (1000 μg/ml) were
50.96, 22.05, and 39.57 respectively (Fig. 1).
3.2.2. In-vitro crystallization of brushite crystals
3.2.2.1. Growth assay. The growth of brushite crystals was mea-
sured as length (thickness of crystal deposition). The crystals
acquired maximum length (approximately 0.35 cm) on day 3
after gelation took place and then after the length of the crys-
tals deposited became constant up to day 8.The average length
of the deposited CHPD crystals was decreased by citric acid
(1 M), CAAE (500 μg/ml) and CAAE (1000 μg/ml) until day 8. The
length of the crystals in control, CAAE (500 μg/ml) and CAAE
(1000 μg/ml) were 0.35 cm, 0.21 cm and 0.133 cm, respec-
tively; however, it could not be measured due to absence of
any measurable size crystals in citric acid (1 M) group. Figs. 3
and 4 show the effects of citric acid and CAAE on the length
of deposited CHPD crystals.
Fig. 5 shows the microphotographs of CHPD crystals in dif-
ferent groups. Crystals in CAAE (500 and 1000 μg/ml) groups
were very small compared to the control, whereas in citric acid
there was no appearance of observable crystals. Citric acid and
CAAE (500 and 1000 μg/ml) significantly decreased the size of
crystals (p < 0.001) as measured by its thickness using stage
micrometer. The microphotographs of the CHPD crystals of
the control showed the plate like crystals having an average
Fig. 1 – Effects of cystone and CAAE on CaOx nucleation,
aggregation and growth.
Fig. 2 – Photomicrographs of CaOx crystal density in different solutions, viz control, cystone (1000 μg/ml), and CAAE (500 μg/
ml and 1000 μg/ml) [A = control, B = cystone, C = CAAE500, D = CAAE1000], magnification 100×.
Fig. 3 – Effects of citric acid and CAAE on the length of
deposited CHPD crystals. Values are mean ± SEM.
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thickness size of 52.64 μm, while the average thickness of the
crystals in CAAE (500 μg/ml) and CAAE (1000 μg/ml) was
17.28 μm and 14.15 μm, respectively (Fig. 6). There were no ob-
servable crystals present in tube containing citric acid (1M).
4. Discussion
The recurrence of stone is a very serious concern in the medical
management of urolithiasis. Drug treatments like thiazide as
diuretic and alkali-citrate, used to prevent the recurrence of
hypercalciuria and hyperoxaluria, are considered to be less
efficacious [4]. Although the surgical endoscopic stone removal
and extracorporeal shock wave lithotripsy have revolution-
ized the treatment of urolithiasis, they increase the chances
of new stone formation [5], and the shock waves in therapeu-
tic doses may cause acute renal injury, decrease in renal
function and an increase in stone recurrence (50–80%).
In view of these, the effect of leaves of C. album, having tra-
ditional use in the treatment of kidney stones and urinary tract
troubles, was studied in in-vitro models of urolithiasis. In in-
vitro calcium oxalate crystallization study, the process of
nucleation and aggregation was studied in sodium acetate
buffer of pH 5.7 to simulate the conditions of urine so as to
favor the above processes. In the crystallization study, the
Fig. 4 – Effects of citric acid and CAAE on the growth of CHPD (brushite crystals) [A1 = control (5th day), A2 = control (8th
day), B1 = before treatment of citric acid (5th day), B2 = after treatment of citric acid (8th day), C1 = before treatment of CAAE
(5th day), C2 = after treatment of CAAE (8th day)].
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turbidity increased linearly up to 5 min and then decreased lin-
early up to 15 min after the addition of calcium chloride
dihydrate. Earlier increase in the turbidity was suggestive of
the nucleation phenomenon, while the decrease in the later
part indicated the aggregation. These two phenomena repre-
sented the complete process of in-vitro crystallization as
observed previously by Hess et al. [2000] [22]. Simultaneous ad-
dition of CAAE (500 and 1000 μg/ml) and cystone (1000 μg/ml)
along with calcium chloride dihydrate inhibited the nucle-
ation as well as aggregation process of CaOx crystallization
as indicated by dose-dependent decrease in turbidity of the
solution in both phenomena. The inhibition of in-vitro crys-
tallization of CaOx suggests that CAAE has influence on the
formation of crystals from sodium oxalate and calcium chlo-
ride and/or their aggregation. Most of the previous papers [25,26]
stated that the test drug or extract inhibited the crystalliza-
tion by favoring the formation of calcium oxalate dihydrate
(COD) crystals instead of calcium oxalate monohydrate (COM).
The study needs a use of polarized light to differentiate between
COM and COD crystals, which is a limitation of the present
study and thus could not state whether the CAAE favored the
formation of COD and less of COM, but the possibility of this
cannot be ignored. The non-significant decrease in turbidity
as observed in the process of aggregation may be due to the
possibility of more amounts of COD crystals in the solution.
Moreover, growth assay showed that CAAE also inhibited the
growth of calcium oxalate monohydrate crystals with maximum
inhibition at 1000 μg/ml concentration.This indicates that CAAE
has inhibitory influence on nucleation/aggregation and growth
of calcium oxalate crystals.
Similarly, CAAE also showed significant inhibition of growth
of brushite (CHPD) crystals and caused their dissolution, in-
dicated by the small length of the crystal deposition thickness
in the test tube (See Figs. 3 and 4) and decreased microscopic
thickness of the crystals (P < 0.001) as compared to control (see
Figs. 5 and 6). CAAE exhibited effects comparable to standard
drug citric acid, which showed the complete dissolution of the
CHPD crystals. The effect of citric acid corroborates with pre-
vious finding [27].The results indicated that CAAE has significant
influence on the formation, growth and dissolution of crys-
tals, and further suggest that the extract has beneficial effect
in preventing the formation of crystals and their growth.
Literature of the previous studies is silent on the exact
mechanism involved in the inhibition of in-vitro crystalliza-
tion and stated that the extracts contained some chemical
components that inhibited the crystallization.There are reports
that flavonoids inhibit calcium oxalate crystallization in human
urine as well as in animal models [28] and crystal deposition
[29]. Saponins showed anti-crystallization properties by
Fig. 5 – Effects of citric acid and CAAE on the size of crystals [A = control, B = citric acid, C = CAAE500, D = CAAE1000],
magnification 400×.
Fig. 6 – Effects of citric acid and CAAE on microscopic
thickness of crystals. Values are expressed as mean ± SEM;
*p<0.001 when compared to control.
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disaggregating the suspension of mucoproteins, the promot-
ers of crystallization [30]. Phytochemical screening and
estimation of important constituents revealed that CAAE con-
tains flavonoids and saponins. It has total flavonoid content
of 87.23 mg quercetin equivalents/g of extract and total sa-
ponins content of 1.6 mg saponins/100g of powder mass. Thus,
the flavonoids and saponins present may be playing a con-
tributing role in anti-crystallization action of CAAE. Fouda et al.
[2006] studied the effect of in-vitro and in-vivo antilithiatic effects
of saponins rich fraction of Herniaria hirsuta and stated that
fraction contained a substance that promoted the nucleation
of COD crystals [25]. Finally, the results of the present inves-
tigations suggest that the leaves of the C. album have in-vitro
anti-crystallization effect on CaOx and brushite crystals. These
findings substantiate the traditional use of the leaves in the
treatment of urinary stones and kidney problems. In order to
substantiate its in-vitro effect, the in-vivo studies need to be
carried out in experimental animals.
5. Conclusion
The leaves of C. album have beneficial inhibitory effect on in-
vitro crystallization of CaOx and CHPD (brushite) crystals.
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